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Introduction. In obese patients with hiatal hernia (HH), laparoscopic sleeve gastrectomy (LSG) with cruroplasty is an option but
use of prosthetic mesh crura reinforcement is debated. The aim was to compare the results of hiatal closure with or without mesh
buttressing during LSG. Methods. Gastroesophageal reflux disease (GERD) was assessed by the Health-Related Quality of Life
(GERD-HRQL) questionnaire before and after surgery in two consecutive series of patients with esophageal hiatus≤ 4 cm2.
After LSG, patients in group A (12) underwent simple cruroplasty, whereas in group B patients (17), absorbable mesh crura
buttressing was added. Results. At mean follow-up of 33.2 and 18.1 months for groups A and B, respectively (p = 0 006), the
mean preoperative GERD-HRQL scores of 16.5 and 17.7 (p = 0 837) postoperatively became 9.5 and 2.4 (p = 0 071). In group
A, there was no difference between pre- and postoperative scores (p = 0 279), whereas in group B, a highly significant
difference was observed (p = 0 002). The difference (Δ) comparing pre- and postoperative mean scores between the two groups
was significantly in favor of mesh placement (p = 0 0058). Conclusions. In obese patients with HH and mild-moderate GERD,
reflux symptoms are significantly improved at medium term follow-up after cruroplasty with versus without crura buttressing
during LSG.
1. Introduction
Hiatal hernia (HH) and gastroesophageal reflux disease
(GERD) are often concomitant conditions and are more fre-
quent in obese than in nonobese patients [1]. The prevalence
of HH in obese patients ranges from 5 to 50% [2–4]. Several
factors contribute to HH development: increased intrabdom-
inal pressure, increased visceral fat, congenital gastroesopha-
geal junction anomalies, and chronic reflux [5, 6]. Patients
who are candidates to bariatric surgery often present with
GERD, with a 50–70% incidence rate [5, 6]. The treatment
of choice in obese patients with GERD symptoms is laparo-
scopic Roux-en-Y gastric bypass (LRYGB) [7, 8]. However,
patients’ demand is more frequently in favor of laparoscopic
sleeve gastrectomy (LSG), which is felt by patients to be asso-
ciated with lower morbidity and does not require long-term
vitamins and elemental nutrient support; the cost of which
is not covered by the health system.
LSG is currently the most common surgical procedure
for the treatment of morbid obesity, both in Europe and
in the USA [9, 10], but its results in relation to GERD
symptoms are controversial [11–13]. Some authors report
improved symptoms after weight loss, while others report
de novo GERD in patients who were asymptomatic before
surgery [11–13].
When a HH is present, simultaneous repair is possible
and recommended during LSG [14, 15]. Two techniques
have been proposed: after reduction in the peritoneal cavity
of the herniated stomach and abdominal esophagus, the
diaphragmatic crura are sutured together anteriorly or, pref-
erably, posteriorly (simple cruroplasty) [16]. After cruro-
plasty, the diaphragmatic crura may be buttressed with
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nonabsorbable mesh, although the use of this type of mesh
has been reported to be at a higher risk of esophageal stric-
ture, erosion, or perforation [17]. Alternatively, it is possible
to reinforce the diaphragmatic crura with an absorbable
synthetic patch fixed by absorbable tacks [16, 18]. This patch
causes the development of granulation tissue and neoangio-
genesis at the level of the crura, and it is completely reab-
sorbed after six to eight months [16, 18]. The fibrotic tissue
that remains after mesh absorption is meant to reduce the
risk of HH recurrence [16, 18].
The aim of this retrospective study was to compare the
results of simple posterior cruroplasty versus reinforced crur-
oplasty during LSG, in terms of GERD symptoms, in patients
with an esophageal hiatal area measuring≤ 4 cm2.
2. Materials and Methods
This is a retrospective analysis of prospectively collected data.
Institutional review board approval and informed consent
from all individual participants included in the study were
obtained. From October 2006 to April 2017, 157 obese
patients underwent LSG in the “Clinica Chirurgica e Tecno-
logie Avanzate,”Department of General Surgery and Surgical
Specialties “Paride Stefanini,” Policlinico Umberto I,
“Sapienza” University of Rome, Italy, a unit that was mainly
devoted to minimally invasive oncologic surgery. Laparo-
scopic hiatoplasty in obese patients was performed since
May 2011.
At admission, the patients were assessed according to
National and International Guidelines [19], as previously
reported [20], and included in the study. Exclusion criteria
were body mass index (BMI)< 35 kg/m2, patients at prohib-
itively high risk for general anesthesia and induction of
pneumoperitoneum, hiatus area> 4 cm2, sweet eaters, preg-
nancy, alcohol or drug consumption, and severe psychiatric
disorders. The HH size was evaluated preoperatively by
endoscopy. The esophageal hiatus area was calculated intra-
operatively as the area of the rhomboid space that is crossed
by the esophagus d1 × d2/2 [16].
Patients with HH and a hiatus area measuring≤ 4 cm2
underwent either LSG, hernia reduction, and simple cruro-
plasty (group A) prior to absorbable patch availability in our
hospital or LSG, hernia reduction, and cruroplasty reinforced
by absorbable patch placement (group B), subsequently.
GERD symptoms were assessed by a Health-Related Quality
of Life (GERD-HRQL) questionnaire before and after surgery
[21]. Postoperatively, HH recurrence was evaluated by
barium swallow.
2.1. Questionnaire. The gastroesophageal reflux disease-
Health-Related Quality of Life (GERD-HRQL) is a patient
self-rating questionnaire comprising 10 questions that specif-
ically investigate GERD symptoms, each one with a score
from 0 (absence of symptoms) to 5 (severe symptoms), for
a total score that may range from 0 to 50 [21].
2.2. Surgical Technique. Surgery was performed with the
patient in supine, steep anti-Trendelenburg position, and
operative table tilted with the patient’s right side down, in
order to improve exposure of the operative field. The surgeon
stood in between the patient’s legs.
Pneumoperitoneum was established with an optical
trocar and a 30° optic. The first 12mm trocar was inserted left
of the midline, at a point at the junction between the upper
two thirds and the lower third of the line between the xiphoid
process and umbilicus. The second and third 12mm trocars
were placed along the left and right pararectal lines, two
fingerbreadths below the costal arches. A fourth 5mm trocar
was placed in a subxiphoid position, right of the midline, and
a fifth 5mm trocar was placed in the left hypochondrium,
along the anterior axillary line [20]. The first step of the
procedure was the division of the gastric greater curvature
attachments to the greater omentum by means of a radiofre-
quency (LigaSure™ tissue fusion, Covidien, Mansfield,
Massachusetts, USA) or ultrasonic (Ultracision, harmonic
scalpel, Ethicon Endo-Surgery, Cincinnati, Ohio, USA)
device, starting 5 cm from the pylorus and proceeding orally
up to the angle of His. The left and right bundles of the right
crus of the esophageal hiatus were exposed, and the upper
stomach, gastroesophageal junction, and lower esophagus
were circumferentially mobilized until the stomach and
approximately 4 cm of intra-abdominal esophagus were
reduced in the abdominal cavity. LSG was then performed
with a linear stapler (Echelon Flex Powered Endopath, Ethi-
con Endo-Surgery, Johnson & Johnson, Cincinnati, OH),
beginning with 2 green or black cartridges on the antrum,
followed by 2–4 green cartridges on the body and fundus,
all reinforced by Seam-guard® (Gore & Associates, Inc.,
Newark, Delaware, USA), starting 5 cm proximal to the pylo-
rus under guidance of an orogastric 36 Fr bougie laid along
the smaller curvature of the stomach. After sleeve creation,
in group A, the left and right bundles of the right crus were
sutured together posteriorly to the esophagus with the bougie
in place, with 2 or 3 stitches of a nonabsorbable 2.0 braided
polyester suture (Ethibond, Ethicon, Cincinnati, Ohio,
USA). In group B, after hiatal closure was completed, a “U”
shaped polyglycolic acid-trimethylene carbonate absorbable
synthetic patch (mesh Bio-A®, Gore & Associates, Inc.,
Newark, Delaware, USA) was fixed with absorbable tacks
(AbsorbaTack 5mm Fixation Device, Covidien, Mansfield,
Massachusetts, USA) to the crura. Care was taken to avoid
placing mesh and tacks in contact with the esophagus. After
removing the bougie, the resected portion of the stomach was
extracted after enlarging the trocar site above the umbilicus.
2.3. Measures of Outcomes. The primary endpoint was an
improvement of GERD symptoms, as recorded by the
GERD-HRQL questionnaire score evaluation before and
after surgery in the two groups. Secondary endpoints were
operative time, conversion rate, intra- and postoperative
complications (according to Clavien-Dindo classification
[22]), hospital stay, mortality, postoperative BMI, and per-
centage excess body mass index loss (%EBMIL). In case of
leaks, these were classified according to the International
Sleeve Gastrectomy Expert Panel Consensus Statement [15].
2.4. Statistical Analysis. Statistical analysis was performed
using the t-test, and data are presented as mean± standard
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deviation (SD). Fisher’s exact test was used to evaluate the
difference within groups. A probability (p) value lower than
0.05 was considered statistically significant. All statistical
analyses were carried out with SPSS software 19.0 (SPSS
Inc., Chicago, Illinois, USA).
3. Results and Discussion
3.1. Results. Out of a total series of 157 patients who under-
went LSG, 12 patients with HH underwent simple cruro-
plasty from May 2011 to March 2014 (group A), and 21
patients with HH underwent cruroplasty with mesh but-
tressing from April 2014 to April 2017 (group B). Among
group B patients, 1 had an esophageal hiatus area measur-
ing more than 4 cm2 and was excluded from the present
analysis, and 3 patients were lost at follow-up, leaving 12
and 17 patients in groups A and B, respectively, who were
available for the study.
Tables 1 and 2 show the patients’ characteristics. Before
surgery, the only statistically significant difference that was
observed between the two groups was the rate of preoperative
diagnosis of HH, more frequent in group B (p = 0 0382)
(Table 2). However, no significant differences between the
two groups were observed in the incidence of GERD symp-
toms and esophagitis (Table 2).
Mean operative time, in groups A and B, was 195.4 ± 51.9
minutes (range 130–300 minutes) and 184.3 ± 39.09 minutes
(range 130–300 minutes), respectively (p = 0 5326). At sur-
gery, a statistically significant difference was observed
between the two groups in the rate of intraoperative diagno-
sis of HH (p = 0 0382) (Table 2). Conversion to open surgery,
postoperative complications, or mortality was not observed
in the two groups (Table 3). Mean hospital stay was
5.6 ± 1.3 days (range 3–8 days) and 5± 1.06 days (range 3–7
days) for groups A and B, respectively (p = 0 1511) (Table 3).
At mean follow-up of 33.2 ± 16.3 months (range 14–72
months) and 18.1± 11.3 months (range 1–38 months)
(p = 0 0066) for groups A and B, respectively (Table 4), post-
operative BMI was lower and %EBMIL was higher in group
A as compared to group B, with a statistically significant
difference (Table 4). Intergroup evaluation showed a highly
statistically significant difference comparing the pre- and
postoperative questionnaire scores in group B (Table 5). No
statistically significant differences were observed comparing
the pre- and postoperative GERD-HRQL mean scores
between the two groups, although the difference (Δ) between
the pre- and postoperative GERD-HRQL mean scores
between the two groups was statistically significant in favor
of patch placement (p = 0 0058) (Table 5).
Evaluating only the dysphagia by questionnaire items
7 and 8, mean preoperative scores were 1.58± 2.94
(range 0–8) and 2.53± 3.56 (range 0–12) for groups A and B,
respectively (p = 0 4560). Mean postoperative scores were
0.92± 2.87 (range 0–10) and 0.88± 1.90 (range 0–7) for
groups A and B, respectively (p = 0 9693). The Δ between
pre- and postoperative mean dysphagia scores in the two
groups was statistically significant in favor of patch
placement (p = 0 0498).
Table 1: Patients’ characteristics.
Group A
n = 12
Group B
n = 17 p value
Sex ratio (F :M) 10 : 2 13 : 4 1.0000
Mean age± SD, years (range) 46.4± 11 (32–65) 48.4± 9.2 (31–63) 0.5918
Preoperative BMI± SD, kg/m2 (range) 42.1± 8.3 (35–61) 43.5± 4.7 (35–51) 0.5757
T2DM, n (%) 6 (50) 11 (64.7) 0.4713
Hypertension, n (%) 7 (58.3) 8 (47.05) 0.7104
Sleep apnea syndrome, n (%) 9 (75) 11 (64.7) 0.6942
Mild–moderate, n (%) 6 (50) 7 (63.6) 0.7163
Severe needing CPAP^, n (%) 3 (25) 4 (23.5) 1.0000
Previous bariatric surgery, n (%) 0 0 1.0000
SD: standard deviation; BMI: body mass index; T2DM: type 2 diabetes mellitus. ^: continuous positive airway pressure.
Table 2: Symptoms, endoscopy, and biopsy findings.
Group A
n = 12
Group B
n = 17 p value
GERD symptomatic patients, n (%) 8 (66.6) 9 (52.9) 0.7032
Preoperative diagnosis of HH, n (%) 6 (50) 15 (88.2) 0.0382∗
Intraoperative diagnosis of HH, n (%) 6 (50) 2 (11.7) 0.0382∗
Preoperative grade A esophagitis, n (%) 4 (33.3) 4 (23.5) 0.6828
Eradicated Helicobacter pylori, n (%) 3 (25) 8 (47.05) 0.2732
GERD: gastroesophageal reflux disease; HH: hiatal hernia. ∗Statistically significant differences in bold.
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Symptoms of de novo GERD were observed in one group
A patient (GERD-HRQL score: preoperative 0, postoperative
13) and in one group B patient (GERD-HRQL score: preop-
erative 0, postoperative 12). HH recurrence was observed in
two group A patients (16.6%) who underwent revisional lap-
aroscopic gastric bypass between one and two years after LSG
for severe GERD symptoms confirmed by pH manometry
testing (postoperative GERD-HRQL scores 42 and 35, resp.).
In one of these two patients, severe GERD symptoms signif-
icantly increased after pregnancy. HH recurrences were not
observed in group B.
3.2. Discussion. The treatment of choice in obese patients
with GERD symptoms is laparoscopic Roux-en-Y gastric
bypass [7, 8]. However, patients’ demand is more often in
favor of laparoscopic sleeve gastrectomy (LSG), which in
the patients’ opinion is felt to be associated with lower
morbidity, and it does not require long-term vitamins and
elemental nutrient supplementation; the cost of which has
to be covered by the patients themselves. However, LSG
cannot be proposed to obese patients with severe GERD or
to sweet eaters, and LRYGB has proven to be an excellent
option in these cases [23]. The first LRYGB in the authors’
unit was performed in March 2016, and since then, nine
patients have undergone this procedure. Hiatoplasty with
patch placement was performed in four out of these nine
patients. The indication to perform LRYGB was in obese
patients with GERD symptoms and/or sweet eating habits.
The present study is a retrospective analysis of two con-
secutive series of morbidly obese patients with HH who
underwent LSG and one of the two types of hiatal closure,
namely, simple posterior cruroplasty or posterior cruroplasty
reinforced by a synthetic patch. Cruroplasty with mesh but-
tressing was associated with better results in terms of GERD
symptoms control as compared to cruroplasty alone. The two
groupswere identical in termsof preoperative anthropometric
Table 4: Mean follow-up, pre- and postoperative BMI, and %EBMIL for each group.
Group A
n = 12
Group B
n = 17 p value
Mean follow-up± SD, months (range) 33.2± 16.3 (14–72) 18.1± 11.3 (1–38) 0.0066∗
Postoperative BMI± SD, kg/m2 (range) 29.7± 4.1 (22–36) 32.8± 3.2 (26–40) 0.0317∗
%EBMIL± SD (range) 74.1± 23.1 (39–118) 57.8± 15.7 (31–88) 0.0315∗
SD: standard deviation; BMI: body mass index; EBMIL: excess body mass index loss. ∗Statistically significant differences in bold.
Table 5: GERD-HRQL questionnaire score.
Group A
n = 12
Group B
n = 17 p value
Mean preoperative GERD-HRQL score± SD (range) 16.5± 16.6 (0–45) 17.7± 14.1 (0–45) 0.8379
Mean postoperative GERD-HRQL score± SD (range) 9.5± 14.6 (0–42) 2.4± 4.7 (0–15) 0.0712
p value 0.2793 0.0002∗
Δ mean GERD-HRQL score± SD −7± 2 −15.3± 9.4 0.0058∗
SD: standard deviation. ∗Statistically significant differences in bold. Δ: difference.
Table 3: Postoperative results.
Group A
n = 12
Group B
n = 17 p value
Mean operative time± SD, min (range) 195.4± 51.9 (130–300) 184.3± 39.09 (130–300) 0.5326
Conversion, n (%) 0 0 1.0000
Complications, n (%) 0 0 1.0000
Leaks, n (%) 0 0 1.0000
Associated procedures, n (%) 5 (41.6) 3 (17.6) 0.2180
Cholecystectomy 4 (33.3) 3 (17.6) 0.4029
Intraoperative ERCP/ES^ 1 (8.3) 0 0.4138
Mean hospital stay± SD, days (range) 5.6± 1.3 (3–8) 5± 1.06 (3–7) 0.1511
Mortality, n (%) 0 0 1.0000
SD: standard deviation. ^: endoscopic retrograde cholangiopancreatography/endoscopic sphincterotomy.
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characteristics and GERD symptoms, and patient allocation
to the two arms of the study was based only on absorbable
mesh availability in the hospital.
Reinforced cruroplasty during LSG in patients with large
hiatal hernia has been proposed to prevent recurrence, with
good results [16]. In the present series, the esophageal hiatus
area measured≤ 4 cm2. The authors hypothesized that a rein-
forced cruroplasty with absorbable patch during LSG might
provide better results in terms of prevention of HH recur-
rence and GERD symptoms control, as compared to simple
posterior cruroplasty, even in patients with smaller hiatal
hernias. This hypothesis was based on the observation that
in obese patients the diaphragmatic crura are substantially
weakened, particularly the right bundle of the right crus, even
if the esophageal hiatus area is not widely dilated. For the
purpose of the present study, patients with an esophageal
hiatus area measuring more than 4 cm2 were excluded from
the analysis.
In the two series being consecutive, postoperative BMI
was lower and %EBMIL was higher in the group with the
longer duration of follow-up (group A), as expected. Quite
surprising, instead, was the highly statistically significant
difference that was observed comparing the pre- and postop-
erative questionnaire scores in group B that is the group with
the higher BMI and the lower %EBMIL (Table 5). The fact
that this effect was observed in patients with as yet less than
optimal average weight control lends credit to the hypothesis
that buttressing the crura might indeed be beneficial for
GERD control in these patients, since this was the only differ-
ing variable. This result seems to contradict the hypothesis
that the improvement of GERD symptoms after LSG alone
might be related to the consequences of weight loss, such as
decreased intra-abdominal pressure, or other factors includ-
ing accelerated gastric emptying and reduced gastric acid
secretion [24, 25]. Based on the present study, in fact, it seems
that a factor contributing to the postoperative improvement
of GERD symptoms after LSG might be the technique of
hiatal closure.
In the authors’ experience, the increase in HH repair
during LSG was related to the recommendation reported in
the literature suggesting a more aggressive approach towards
the identification of any HH, and its repair when this is
present [15].
The results of simple cruroplasty during LSG are still
controversial [1, 26, 27]. Soricelli et al. reported a study in
which 97 patients treated by LSG and posterior cruroplasty
were compared to 281 patients who underwent LSG alone
[1]. At a mean follow-up of 18 months, evaluating remission,
improvement, persistence, and de novo GERD symptoms,
better results were observed in patients undergoing HH
repair [1]. An improvement of GERD symptoms at 6 and
12 months of follow-up was confirmed also by Daes et al.
in a cohort of 134 patients [26]. Instead, Santonicola et al.
reported a series of 78 patients who underwent LSG with
concomitant HH repair by posterior cruroplasty and no
significant decrease in GERD symptoms was observed at a
mean follow-up of 14.6 months [27].
In the literature, few studies on HH repair with mesh
reinforcement are reported [16, 18]. Most papers report
the results of simple anterior or posterior cruroplasty
[1, 26, 27]. El Chaar et al. reported a study in which mesh was
placed at surgeons’ discretion after posterior cruroplasty in
case of HH measuring> 3 cm2, showing an improvement of
postoperative GERD symptoms with or without mesh place-
ment [18]. Ruscio et al. compared simple versus reinforced
hiatoplasty, in patients with a hiatus area measuring≤ 4 cm2
versus 4–8 cm2, respectively [16]. Notwithstanding the dif-
ferent hiatus sizes in the two groups, the patients who
underwent LSG and reinforced hiatoplasty had better results
in terms of GERD symptom control at 19 months after sur-
gery, as compared to patients who underwent simple cruro-
plasty [16]. In this study, recurrent GERD was nil [16].
Another important aspect is that complications related to
mesh placement were not observed in the present series nor
in any other published one regarding hiatal closure during
bariatric procedures [16, 18, 28]. The mesh and tacks
employed in this series are absorbable, and no residual mate-
rial in the hiatus area is observed at one year after surgery
[16]. The mesh is absorbed by the body and replaced 1 : 1
with the patient’s own type I collagen. In the literature, the
use of absorbable mesh is associated with the absence of
mesh-related complications [17, 29–31] as compared to
nonabsorbable mesh placement for which mesh-related
complications range between 1.3% and 20% [32–34].
The weaknesses of the present study are its retrospective
nature, the small sample size of both groups, the lack of a
standardized time of questionnaire administration, and the
lack of preoperative pH-manometry data before LSG for
more objective assessment of GERD. Moreover, the follow-
up duration of group B is not long enough to draw definitive
conclusions regarding long-term GERD outcomes. Finally,
the sensitivity and specificity of questionnaires to detect
GERD are reported to range between 65% and 75% [35, 36].
4. Conclusions
In conclusion, in patients with HH measuring up to 4 cm2,
hiatal closure with or without mesh placement to reinforce
the esophageal hiatus during LSG is both feasible and safe.
Postoperative GERD symptoms improve with both tech-
niques, but the improvement is highly statistically significant
only with the use of mesh (p = 0 0002). Moreover, the dif-
ference (Δ) between pre- and postoperative GERD-HRQL
mean scores in the two groups was statistically significant
(p = 0 0058) and in favor of patch placement. In any case,
a longer follow-up duration in group B is needed to confirm
these data.
According to the available evidence, LSG with simple
cruroplasty in patient with symptomatic severe GERD is
not indicated, and LRYGB is the treatment of choice in these
patients. In patients with mild/moderate reflux symptoms,
however, LSG with cruroplasty and patch placement showed
interesting postoperative GERD outcomes in the present
series, taking into account also the frequent patients’ demand
to receive a LSG rather than a gastric bypass. Further studies
including pH manometry evaluation, larger patients’ series
with longer follow-up duration, and a randomized study
design are required to better evaluate these results.
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